Abstract
BRAIN-derived neurotrophic factor (BDNF), present in minute amounts in the adult central nervous system1, is a member of the nerve growth factor (NGF) (ref. 2) family, which includes neurotrophin-3 (NT-3) (refs 3–5). NGF, BDNF and NT-3 all support survival of subpopulations of neural crest-derived sensory neurons3–5; most sympathetic neurons are responsive to NGF (ref. 2), but not to BDNF1,6,7; NT-3 and BDNF, but not NGF (ref. 6), promote survival of sensory neurons of the nodose ganglion3–8. BDNF, but not NGF, supports the survival of cultured retinal ganglion cells9 but both NGF and BDNF promote the survival of septal cholinergic neurons in vitro10,11. However, knowledge of their precise physiological role in development and maintenance of the nervous system neurons is still limited. The BDNF gene is expressed in many regions of the adult CNS12‐14, including the striatum12. A protein partially purified from bovine striatum, a target of nigral dopaminergic neurons, with characteristics apparently similar to those of BDNF, can enhance the survival of dopaminergic neurons in mesencephalic cultures15. BDNF seems to be a trophic factor for mesencephalic dopaminergic neurons, increasing their survival, including that of neuronal cells which degenerate in Parkinson's disease. Here we report the effects of BDNF on the survival of dopaminergic neurons of the developing substantia nigra.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Barde, Y.-A., Edgar, D. & Thoenen, H. EMBO J 1, 549–553 (1982).
Levi-Montalcini, R. & Angeletti, P. U. Physiol. Rev. 48, 534–569 (1968).
Hohn, A., Leibrock, J., Bailey, K. & Barde, Y.-A. Nature 344, 339–341 (1990).
Maisonpierre, P. C. et al. Science 247, 1446–1451 (1990).
Rosenthal, A. et al. Neuron 4, 767–773 (1990).
Lindsay, R. M., Thoenen, H. & Barde, Y.-A. Devl Biol. 112, 318–328 (1985).
Davies, A. M., Thoenen, H. & Barde, Y.-A. J. Neurosci. 6, 1897–1904 (1986).
Hofer, M. M. & Barde, Y.-A. Nature 331, 261–262 (1988).
Johnson, J. E., Barde, Y.-A., Schwab, M. & Thoenen, H. J. Neurosci. 6, 3031–3038 (1986).
Hartikka, J. & Hefti, F. J. Neurosci. 8, 2967–2985 (1988).
Alderson, R. F., Alterman, A. L., Barde, Y.-A. & Lindsay, R. M. Neuron 5, 297–306 (1990).
Hofer, M., Pagliusi, S. R., John, A., Leibrock, J. & Barde, Y.-A. EMBO J. 9, 2459–2464 (1990).
Maisonpierre, P. C. et al. Neuron 5, 501–509 (1990).
Phillips, H. S., Hains, J. M., Laramee, G. R., Rosenthal, A. & Winslow, J. W. Science 250, 290–294 (1990).
Dal Toso, R. et al. J. Neurosci. 8, 733–745 (1988).
Bignami, A., Eng, L. F., Dahl, D. & Uyeda, C. T. Brain Res. 43, 429–435 (1972).
Knusel, B., Michel, P. P., Schwaber, S. & Hefti, F. J. Neurosci. 10, 558–570 (1990).
Rodriguez-Tébar, A., Dechant, G. & Barde, Y.-A. Neuron 4, 487–492 (1990).
Chandler, C. E., Parson, L. M., Hosang, M. & Shooter, E. M. J. biol. Chem. 259, 6882–6889 (1984).
Zigmond, M. J. & Stricker, E. M. Int. Rev. Neurobiol. 31, 1–79 (1989).
Sanchez-Ramos, J. R., Barrett, J. N., Goldstein, M., Weiner, W. & Hefti, F. Neurosci. Lett. 72, 215–220 (1986).
Sanchez-Ramos, J., Michel, P., Weiner, W. J. & Hefti, F. J. Neurochem. 50, 1934–1944 (1988).
Michel, P. P., Dandapani, B. K., Knusel, B., Sanchez-Ramos, J. & Hefti, F. J. Neurochem. 54, 1102–1109 (1990).
Prochiantz, A., DiPorzio, U., Kato, A., Berger, B. & Glowinski, J. Proc. natn. Acad. Sci. U.S.A. 76, 5387–5391 (1979).
DiPorzio, U., Daguet, M.-C., Glowinski, J. & Prochiantz, A. Nature 288, 370–373 (1980).
Prochiantz, A., Daguet, M.-C., Herbert, A. & Glowinski, J. Nature 293, 570–572 (1981).
Denis-Donini, S., Glowinski, J. & Prochiantz, A. J. Neurosci. 3, 2292–2299 (1983).
Ferrari, G., Minozzi, M. C., Toffano, G., Leon, A. & Skaper, S. D. Devl Biol. 133, 140–147 (1989).
Otto, D. & Unsicker, K. J. Neurosci. 10, 1912–1921 (1990).
Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Science 219, 979–980 (1983).
Langston, J. W., Forno, L. S., Rebert, C. S. & Irwin, I. Brain Res. 292, 390–394 (1984).
Bottenstein, J. E. & Sato, G. H. Proc. natn. Acad. Sci. U.S.A. 76, 514–517 (1979).
Wray, W., Boulikas, T., Wrax, V. P. & Hancock, R. Analyt. Biochem. 118, 197–203 (1981).
Yancopoulos, G. D. et al. Cold Spring Harb. Symp. quant. Biol. (in the press).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Hyman, C., Hofer, M., Barde, YA. et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230–232 (1991). https://doi.org/10.1038/350230a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/350230a0
Further reading
-
Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson’s disease: a systematic review and meta-analysis
Neurological Sciences (2022)
-
Plasma brain-derived neurotrophic factor (BDNF) in Egyptian children with attention deficit hyperactivity disorder
Middle East Current Psychiatry (2021)
-
Increased subcortical region volume induced by electroconvulsive therapy in patients with schizophrenia
European Archives of Psychiatry and Clinical Neuroscience (2021)
-
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
Journal of Neurology (2021)
-
The relationship between job stress and job burnout moderated by BDNF rs6265 polymorphism
Psychopharmacology (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.